微芯生物：西达本胺片获批在澳门上市

Core Viewpoint - Microchip Biotech (688321) has received approval from the Macao Special Administrative Region's Drug Supervision Administration (ISAF) for the market launch of its drug, Sidabenamine Tablets [1] Company Summary - The approval for Sidabenamine Tablets marks a significant milestone for Microchip Biotech, potentially expanding its product offerings in the pharmaceutical market [1]